Showing 81 - 100 results of 101,118 for search '(( 12 mg decrease ) OR ( 5 ((((nn decrease) OR (a decrease))) OR (teer decrease)) ))', query time: 1.10s Refine Results
  1. 81
  2. 82
  3. 83
  4. 84
  5. 85

    2-NBDG<sub>60</sub> is sensitive to a decrease in blood glucose levels. by Narasimhan Rajaram (474255)

    Published 2015
    “…There are no significant differences between the 6 and 12-hour fasting groups. <b>C</b>. Blood glucose measurements were performed using a Freestyle Lite monitor by drawing 3 μl of blood from the tail of a separate cohort of mice (n = 5). …”
  6. 86
  7. 87
  8. 88
  9. 89

    Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

    Published 2013
    “…In this study, we examined if certain microRNAs (miRNA) are associated with decreased hepatic CYP3A activity in cirrhosis.</p> <p>Methods</p><p>Hepatic CYP3A activity and miRNA microarray expression profiles were measured in cirrhotic (n=28) and normal (n=12) liver tissue. …”
  10. 90

    Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

    Published 2015
    “…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”
  11. 91
  12. 92
  13. 93
  14. 94
  15. 95
  16. 96

    Trial profile. by Chanel Avenant (409756)

    Published 2024
    Subjects:
  17. 97
  18. 98

    Heparin (GAG-hed) inhibits LCR activity of Human Papillomavirus type 18 by decreasing AP1 binding-5 by Rita Villanueva (65963)

    Published 2011
    “…Nuclear extracts obtained from HeLa cells were exposed to GAG-hed at indicated concentrations for 10 min before labelled probe addition (Panels B and D). On panel A and C, complex specificity is denoted by competition assays with a 100 fold excess of indicated oligonucleotide competitor. …”
  19. 99
  20. 100